General - Press Releases

Date	Title	Company
03-Jan-2022	CORRECTING and REPLACING(1): NOXXON Secures €17 Million Expansion of Equity-linked Facility With Atlas to Advance NOX-A12 in Glioblastoma and Pancreatic Cancer Programs	Businesswire
03-Jan-2022	Pryor Cashman Elects Six New Partners and Promotes Eleven to Counsel	Businesswire
03-Jan-2022	The PhagECOLI Project Undertaken by Pherecydes Pharma and the CEA Receives a €2 Million Grant From Bpifrance	Businesswire
03-Jan-2022	FDA Grants ILiAD Biotechnologies Fast Track Designation for Next Generation Pertussis Vaccine BPZE1	Businesswire
03-Jan-2022	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older	Businesswire
03-Jan-2022	Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board	Newswire
03-Jan-2022	Transcat Expands Service Business and Geographic Reach with Acquisition of Tangent Labs	Businesswire
03-Jan-2022	CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer	Businesswire
03-Jan-2022	Trinseo Completes Acquisition of Heathland B.V.	Businesswire
03-Jan-2022	Amylyx Pharmaceuticals Announces Launch of Initial Public Offering	Businesswire
03-Jan-2022	4D pharma appoints John Doyle as Chief Financial Officer	Businesswire
03-Jan-2022	Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels	Businesswire
28-Dec-2021	Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences	Newswire
28-Dec-2021	Can British stoicism cause more harm than good? New study reveals that Brits have the highest resilience and sense of solidarity in Europe since the start of the COVID-19 pandemic, but many could be masking mental health issues and not asking for help	Merck
23-Dec-2021	MHRA approves licence extension for Novartis’ targeted therapy for advanced breast cancer patients in Great Britain	Novartis
22-Dec-2021	Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions	Newswire
21-Dec-2021	Research Partnership ranks 12th in fastest growing UK market research agency league tables	Research Partnership
20-Dec-2021	Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference	SMi Group
20-Dec-2021	Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein Discovered Through PTC Therapeutics’ Innovative Splicing Platform	PTC Therapeutics
20-Dec-2021	SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only	SMi Group